BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25293793)

  • 1. [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].
    Nao T; Shimamoto T; Karashima T; Kamei M; Fukuhara H; Fukata S; Satake H; Ashida S; Yamasaki I; Kamata M; Inoue K; Yamanishi T; Ogawa Y; Ito S; Shuin T
    Hinyokika Kiyo; 2014 Sep; 60(9):415-20. PubMed ID: 25293793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conservative therapy by percutaneous radiofrequency ablation of renal cell carcinomas--therapeutic experiments of four patients with seven renal tumors--].
    Karashima T; Inoue K; Shimamoto T; Yamasaki I; Kamada M; Shuin T
    Hinyokika Kiyo; 2006 Apr; 52(4):241-7. PubMed ID: 16686349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
    Park BK; Kim CK; Park SY; Shen SH
    Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-guided radiofrequency ablation of a renal tumor abutting vascular pedicle in a patient with von Hippel Lindau disease.
    Park BK; Kim CK
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):840-2. PubMed ID: 19067041
    [No Abstract]   [Full Text] [Related]  

  • 5. Laser navigation for radiofrequency ablation.
    Varro Z; Locklin JK; Wood BJ
    Cardiovasc Intervent Radiol; 2004; 27(5):512-5. PubMed ID: 15383857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
    Wessendorf J; König A; Heers H; Mahnken AH
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results.
    Iwamoto Y; Kanda H; Yamakado K; Soga N; Arima K; Takeda K; Sugimura Y
    Fam Cancer; 2011 Sep; 10(3):529-34. PubMed ID: 21503747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.
    Gao Y; Xu M; Xu ZF; Liu DW; Tu XA; Zheng YL; Wang DH; Sun XZ; Zheng FF; Qiu SP; Lü MD; Zhang YY; Xie XY; Deng CH
    J Xray Sci Technol; 2012; 20(1):121-9. PubMed ID: 22398592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
    Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
    Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].
    Anai H; Nagata T; Sato T; Minoshima K; Horie M; Yoshiya K; Uchida H; Kichikawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2303-5. PubMed ID: 21224555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease.
    Chambers TP; Fishman EK; Hruban RH
    Clin Imaging; 1997; 21(1):40-2. PubMed ID: 9117930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
    Duffey BG; Choyke PL; Glenn G; Grubb RL; Venzon D; Linehan WM; Walther MM
    J Urol; 2004 Jul; 172(1):63-5. PubMed ID: 15201738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
    Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
    J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.
    Shinohara N; Nonomura K; Harabayashi T; Togashi M; Nagamori S; Koyanagi T
    J Urol; 1995 Dec; 154(6):2016-9. PubMed ID: 7500447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease.
    Shingleton WB; Sewell PE
    J Urol; 2002 Mar; 167(3):1268-70. PubMed ID: 11832711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
    Meister M; Choyke P; Anderson C; Patel U
    Clin Radiol; 2009 Jun; 64(6):589-600. PubMed ID: 19414081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
    Pautler SE; Pavlovich CP; Mikityansky I; Drachenberg DE; Choyke PL; Linehan WM; Wood BJ; Walther MM
    Can J Urol; 2001 Aug; 8(4):1330-3. PubMed ID: 11564277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
    Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
    Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
    Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
    Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal-pleural fistula after radiofrequency ablation of renal tumor in VHL patient].
    Mouracade P; Salin A; Rouach Y; Timsit MO; Joly D; Correas JM; Mejean A
    Prog Urol; 2011 Jun; 21(6):432-6. PubMed ID: 21620305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.